Clinical Trial Update: Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth with Diabetes in Bangladesh [Phase 4]

View source ↗

Summary

Phase 4 trial assessing Basaglar insulin glargine for clinical outcomes and quality of life in youth with Type 1 diabetes in Bangladesh has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Basaglar (insulin glargine)

Snippet

Sponsor: Life for a Child Program, Diabetes Australia | Conditions: Type I Diabetes | Phase 4 | Status: COMPLETED